Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Regional Hospital Bellinzona, officially known as Ospedale Regionale di Bellinzona e Valli (ORBV), is a prominent public healthcare institution located in the Canton of Ticino, Switzerland. As a core member of the Ente Ospedaliero Cantonale (EOC) network, it provides comprehensive medical services across two main sites: the San Giovanni Hospital in Bellinzona and the Faido facility. The hospital is recognized as a multidisciplinary center of excellence, offering specialized care in areas such as oncology, cardiology, neurology, and emergency medicine. It serves as a vital teaching hospital, maintaining academic affiliations with the Università della Svizzera italiana (USI) and other major Swiss universities. ORBV is deeply integrated into the regional life sciences ecosystem, collaborating closely with the Institute of Oncology Research (IOR) and the Institute for Research in Biomedicine (IRB). The facility is also a significant hub for clinical trials, particularly in oncology through its partnership with the Swiss Group for Clinical Cancer Research (SAKK).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Regional Hospital Bellinzona.